Non-invasive imaging of immune cell activation using a nanobody-based immunotracer targeting human CD69

Tessa De Pauw (VUB)
Presentation: “Non-invasive imaging of immune cell activation using a nanobody-based immunotracer targeting human CD69”

Focusing on the role of immune activation in disease and therapy, Tessa De Pauw presented her work on a nanobody-based immunotracer targeting human CD69. CD69 is an early activation marker expressed on immune cells, making it a highly relevant target for studying immune responses in vivo. Her research explores how this tracer can be used for non-invasive imaging of immune cell activation, providing insights into when and where immune responses occur. By enabling more precise visualisation of immune dynamics, this work contributes to improving the monitoring of immunotherapy and supports the development of more targeted and personalised treatment strategies in oncology and beyond.